Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 01, 2024
Cytomos announced the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser.
read more
Wednesday, February 03, 2021
Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
read more
CYTENA a provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a biologics CDMO that manufactures recombinant proteins.
read more
Wednesday, March 10, 2021
Cytel has launched East Bayes®, a web-based extension of the East® platform that enables adoption of computationally intensive Bayesian clinical trial designs.
read more
Cytel and Axio have merged to create the largest global biometrics organization focused on delivering advanced analytical solutions for the life sciences industry.
read more
Cytel announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019.
read more
Wednesday, September 23, 2020
Cytel has widened the geographical scope of the TOGETHER trial, a study to identify early COVID-19 interventions in underserved low- and middle-income country (LMIC) populations.
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more
Cytel announced the hire of Thomas Bregenzer as the new Global Head of Biostatistics.
read more
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development.
read more
Cytel announced further expansion in Europe with the addition of an office in Basel, Switzerland.
read more
Wednesday, November 06, 2019
Cytel has acquired MTEK Sciences to further expand its advanced real-world analytics (RWA) capabilities.
read more
Monday, September 07, 2020
Cytel has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation.
read more
Sunday, September 18, 2016
The Cystic Fibrosis Foundation has announced the official opening of a new, one-of-a kind research facility in Lexington, Mass. Operated by Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), an affiliate of the CF Foundation, the lab is designed to...
read more
Cyrus Biotechnology announced the release of a novel Antibody Structure Prediction Software tool as part of its Cyrus Bench® platform.
read more